Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions

Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions

  • Manjunath P. Pai
  • Jennifer J. Kiser
  • Paul O. Gubbins
  • Keith A. Rodvold
Publisher:SpringerISBN 13: 9783319724225ISBN 10: 3319724223

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks WagonGOBook ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books ₹95.2Audible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions is written by Manjunath P. Pai and published by Springer. It's available with International Standard Book Number or ISBN identification 3319724223 (ISBN 10) and 9783319724225 (ISBN 13).

The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes – “Mechanisms and Models of Drug Interactions” and “Antimicrobial Drug Interactions”. This volume, “Mechanisms and Models of Drug Interactions,” delivers a text that enhances clinical knowledge of the complex mechanisms, risks, and consequences of drug interactions associated with antimicrobials, infection, and inflammation. The book provides a comprehensive review of basic clinical pharmacology with a focus on metabolism and transporter-mediated drug interactions. The chapters address materials that cannot be retrieved easily in the medical literature, including materials focused on the complex interrelationship of acute infection, inflammation, and the risk of drug interactions in the Drug-Cytokine chapter. The Food-Drug and Herb-Drug interactions chapters remain definitive resources. A new chapter on in vitro modeling of drug interactions is included along with updates on design and data analysis of clinical drug interaction studies. Authoritative discussion of models for regulatory decision-making on drug-drug interactions provides the necessary framework to aid antimicrobial drug development. This concise review of the mechanisms and models of drug interactions provides important insights to health care practitioners as well as scientists in drug development.